Future Health GCC sets regional standard with AABB accreditation

Future Health GCC Stem Cell Bank has been awarded AABB accreditation, one of the most internationally recognised standards for quality, safety, and operational practices in stem cell processing, storage, and distribution.

The accreditation follows a rigorous independent assessment of the organisation’s laboratory operations, quality management systems, technical capabilities, and regulatory compliance. It further strengthens Future Health GCC’s standing with families, healthcare providers, and research institutions across the region, reflecting its commitment to operating in line with established global standards.

Recommended For You

Dubai home loans get one-day digital pre-approval!

Outlook names Dr Ajayya Kumar among 50 visionary leaders of the $5 trillion economy

Iran will treat any attack as 'all-out war against us,' says senior Iran official

Fashion Friday to free prediction contest: How Dubai Racing Carnival draws new crowds

Emirates International School Jumeirah celebrates Winter Wonderland

 

Future Health laboratories holds multiple international licences and accreditations, including those from the Human Tissue Authority, the Medicines and Healthcare products Regulatory Agency (MHRA), Swiss Medic, OFSP, ISO 9001, and now AABB—reflecting a deeprooted culture of quality, safety, and regulatory excellence.

With the addition of AABB accreditation, Future Health GCC further strengthens its standing as one of the most accredited stem cell facilities in the region, providing unmatched confidence in the long-term integrity, safety, and traceability of stored stem cell samples.

Commenting on the achievement, Ahmad Alahmad, CEO of Future Health GCC, said: “Achieving AABB accreditation is a defining milestone for Future Health GCC. Alongside our ISO certifications and GMP-grade laboratories, it positions us as one of the most accredited stem cell facilities in the region and reflects our unwavering commitment to quality, safety, and scientific excellence for families and healthcare partners in regenerative medicine.”

This latest accreditation complements Future Health GCC’s advanced infrastructure, GMPgrade laboratory environments, and continued investment in innovation, technology, and specialised expertise. These strengths support the organisation’s long-term mission to advance regenerative medicine and cellular science while consistently exceeding international standards and stakeholder expectations.

Future Health GCC remains focused on expanding its capabilities in line with global scientific progress, guided by robust governance, transparency, and a continued commitment to excellence. Founded in 2005, the organisation operates the largest cryogenic stem cell storage facility in the UAE and maintains state-of-the-art, GMPgrade laboratories designed to support both current and future applications in regenerative medicine and cellular therapies.